secwatch / observer
8-K filed June 15, 2023, 7:59 PM ET ticker NAUT CIK 0001808805
other confidence high sentiment neutral materiality 0.10

Nautilus Biotechnology holds 2023 annual meeting; reelects three Class II directors

Nautilus Biotechnology, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Nautilus Biotechnology, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-14 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-14
Exact text from the filing
The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified based on the following results of voting: Votes For Votes Against Abstentions 108,805,235 299,293 111,677
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Nautilus Biotechnology, Inc. shareholders approved Election of Class II Directors at the 2023-06-14 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-14
Exact text from the filing
The following nominees were elected to serve as Class II directors, each to hold office until the Company’s 2026 annual meeting of stockholders or until his respective successor has been duly elected and qualified: Nominee Votes For Votes Withheld Broker Non-Votes Parag Mallick 94,833,268 717,809 13,665,128 Matthew McIlwain 92,148,474 3,402,603 13,665,128 Farzad Nazem 95,381,887 169,190 13,665,128
View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Nautilus Biotechnology, Inc. filing history →

Source: SEC EDGAR
accession 0001808805-23-000050
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.